HEADER DE NOVO PROTEIN 04-MAR-15 2N08 TITLE NMR STRUCTURE OF A SHORT HYDROPHOBIC 11MER PEPTIDE IN 25 MM SDS TITLE 2 SOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SHORT HYDROPHOBIC PEPTIDE WITH CYCLIC CONSTRAINTS; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS HYDROPHOBIC PEPTIDE, GLP-1R AGONIST, DE NOVO PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR H.N.HOANG,K.SONG,T.A.HILL,D.R.DERKSEN,D.J.EDMONDS,W.M.KOK, AUTHOR 2 C.LIMBERAKIS,S.LIRAS,P.M.LORIA,V.MASCITTI,A.M.MATHIOWETZ, AUTHOR 3 J.M.MITCHELL,D.W.PIOTROWSKI,D.A.PRICE,R.V.STANTON,J.Y.SUEN, AUTHOR 4 J.M.WITHKA,D.A.GRIFFITH,D.P.FAIRLIE REVDAT 2 27-MAY-15 2N08 1 JRNL REVDAT 1 15-APR-15 2N08 0 JRNL AUTH H.N.HOANG,K.SONG,T.A.HILL,D.R.DERKSEN,D.J.EDMONDS,W.M.KOK, JRNL AUTH 2 C.LIMBERAKIS,S.LIRAS,P.M.LORIA,V.MASCITTI,A.M.MATHIOWETZ, JRNL AUTH 3 J.M.MITCHELL,D.W.PIOTROWSKI,D.A.PRICE,R.V.STANTON,J.Y.SUEN, JRNL AUTH 4 J.M.WITHKA,D.A.GRIFFITH,D.P.FAIRLIE JRNL TITL SHORT HYDROPHOBIC PEPTIDES WITH CYCLIC CONSTRAINTS ARE JRNL TITL 2 POTENT GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1R) AGONISTS. JRNL REF J.MED.CHEM. V. 58 4080 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25839426 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00166 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XPLOR REMARK 3 AUTHORS : BRUNGER, A.T. ET AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2N08 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-MAR-15. REMARK 100 THE RCSB ID CODE IS RCSB104257. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 0.01 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM PEPTIDE, 25 MM SDS, 100% H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XPLOR REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 16.93 46.80 REMARK 500 1 GLU A 3 -16.11 72.28 REMARK 500 2 ALA A 2 -145.12 51.83 REMARK 500 3 ALA A 2 157.31 65.62 REMARK 500 7 ALA A 2 -141.73 53.04 REMARK 500 8 PHE A 10 32.23 -79.68 REMARK 500 10 ALA A 2 -142.69 43.19 REMARK 500 14 PHE A 10 49.43 -71.24 REMARK 500 16 GLU A 3 -54.29 73.96 REMARK 500 17 ALA A 2 -127.74 49.26 REMARK 500 18 ALA A 2 -131.98 53.40 REMARK 500 19 ALA A 2 -136.45 52.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25517 RELATED DB: BMRB REMARK 900 RELATED ID: 2N09 RELATED DB: PDB REMARK 900 RELATED ID: 2N0I RELATED DB: PDB REMARK 900 RELATED ID: 2N0N RELATED DB: PDB DBREF 2N08 A 1 12 PDB 2N08 2N08 1 12 SEQRES 1 A 12 HIS ALA GLU GLY THR PHE THR SER ASP PHE PHE NH2 HET NH2 A 12 3 HETNAM NH2 AMINO GROUP FORMUL 1 NH2 H2 N HELIX 1 1 GLU A 3 PHE A 11 1 9 LINK C PHE A 11 N NH2 A 12 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 98 0 1 1 0 0 0 6 0 0 0 1 END